Quant ratings on Cathie Wood's top holdings: TSLA, CRSP, AMD, and TEM

Quant ratings on Cathie Wood's top holdings: TSLA, CRSP, AMD, and TEM
Cathie Wood’s Ark Invest leaned into volatility on Wednesday, buying shares of Tempus AI after a post-earnings pullback while trimming exposure to Pinterest following recent weakness in its outlook. Tempus AI shares fell more than 7% to $53.71 after the company reported a https://t.co/0IaJbvpWYn
Nancy Pelosi’s investment in Tempus AI is turning heads after the stock surged more than 200% this year. Earlier in 2025, Pelosi disclosed the purchase of 50 call options in Tempus AI, a healthcare-focused artificial intelligence company. The options, which expire in 2026 with a https://t.co/RQcfR1BVPT
Cathie Wood’s Ark Invest made a series of high-profile moves on Tuesday, reshuffling its portfolio across several sectors. The firm increased exposure to Advanced Micro Devices, Bullish, and Figma, while trimming its stake in Tempus AI. Ark’s Fintech Innovation ETF added nearly https://t.co/QvBQeiAvDv
Cathie Wood’s Ark Invest made several high-profile trades this week, shifting away from Tempus AI while increasing positions in Amazon, Figma, and crypto-focused Bullish. Ark sold more than 58,000 shares of Tempus AI across its ARK Genomic Revolution and ARK Innovation funds. https://t.co/DTZ8k1O1wA
Tempus AI announces $81.25M acquisition of Paige
7.48BUSD

Bekijk welke miljardairs deze investering bezitten
Type
Common Stock
Aandelenbeurs
NASDAQ
Valuta code
USD
Valutanaam
US Dollar
Naam van het land
USA
Land-ISO
US
IS IN
US88023B1035
CUSIP
-
Sector
Healthcare
Industrie
Health Information Services
Einde boekjaar
December
IPO-datum
-
Bijgewerkt op
-
P / E verhouding
-
PEG-ratio
-
Boekwaarde
2.32
Dividendaandeel
-
Dividendrendement
-
Winstaandeel
-1.83
Richtprijs Wall Street
67.23
EPS-schatting huidig jaar
-0.36
EPS-schatting volgend jaar
-0.08
EPS-schatting huidig kwartaal
-0.2011
EPS-schatting volgend kwartaal
-0.1483
Meest recente kwartaal
-
Inkomsten TTM
1,364,167,936
Brutowinst TTM
864,734,976
EBITDA
-185,246,000
Winstmarge
-22.21%
Rendement op activa TTM
-9.07%
Rendement op eigen vermogen TTM
-81.58%
Opbrengst per aandeel TTM
7.735
Qtly omzetgroei op jaarbasis
36.10%
Verdunde Eps TTM
-1.83
Qtly winstgroei op jaarbasis
0.00%
Achterlopende PE
0.00
Voorwaarts PE
0
Prijs Verkoop TTM
5.846
Prijsboek MRQ
17.9669
Bedrijfswaarde-inkomsten
5
Bedrijfswaarde EBITDA
0
203.19
0.55%21.11
0.26%0.97
0.00%112.23
0.00%59.68
-18.13%5.52
-6.76%46.54
-5.87%74.71
-0.65%49.87
-0.53%100.62
-0.39%